Impact of serological and PCR testing requirements on the selection of COVID-19 convalescent plasma donors
Convalescent plasma is undergoing randomized trials as a potential therapeutic option for COVID-19 infection. Clearance for donation required successful completion of an online questionnaire and an in-person screening visit. After receiving 3093 online questionnaires, 521 individuals presented for in-person screening visits, with 40.1% (n = 209) fully qualifying.
